Porzio Life Sciences Co-Sponsors, Presents at CBI's 13th Annual Pharmaceutical Compliance Congress
Porzio, Bromberg & Newman attorneys and Porzio Life Sciences executives will speak at CBI's 13th Annual Pharmaceutical Compliance Congress, scheduled April 26 - 27, 2016 in Washington, D.C.
Chief Compliance Officer Summit, April 26, 2016 at 1:30 PM
Summit Host: John P. Oroho
"Data Aggregation - Challenges with Managing Cross-Border Spend," April 26, 2016 at 3:35 PM
Speakers: D. Jeffrey Campbell and Brian P. Sharkey
"Social Media - New Challenges and Opportunities," April 26, 2016 at 4:05 PM
Speakers: Jennifer A. Romanski and Vito A. Gagliardi, Jr.
"Data Analysis, Risk Mitigation and Predictive Analytics," April 27, 2016 at 10:30 AM
Track Chair: John P. Oroho
Attendees: Michelle D. Axelrod, Christine N. Bradshaw, Laura C. Conway, Nancy A. Henshaw, Giuliana L. Politano
Widely recognized as the most comprehensive, senior-level compliance meeting, CBI's esteemed Pharmaceutical Compliance Congress (PCC) attracts more than 400 industry leaders including dozens of CCOs. PCC features first-hand feedback from government agencies including DOJ, FDA and U.S. Attorneys.
- Dedicated, high-level content for senior-level professionals
- Fundamental sessions tailored to those new to the compliance space
- Pertinent, pressing issues facing compliance professionals including FCPA, considerations for BRIC nations, compliance for specialty products, third-party investigations
- The industry's only CCO Summit
- The Enforcement Panel
For more information, please click here.